X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216361
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212137
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216909
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-march-15-2023-86840.pdf
https://endpts.com/apotex-issues-recall-of-eye-treatment-over-cracks-in-the-bottle-caps/
https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/apotex-corp-issues-voluntary-nationwide-recall-brimonidine-tartrate-ophthalmic-solution-015-due
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216361
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=078480
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215598
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=091086
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=201949
https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-litigation-for-simbrinza-brinzolamide-and-brimonidine-tartrate-26922.pdf
https://www.fiercepharma.com/pharma/ocugen-stares-down-10000-fine-over-missing-clinical-trial-data-fda#:~:text=The%20FDA%20has%20warned%20Ocugen,patients%20with%20dry%20eye%20disease.
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=091442
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=091087
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=078479
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203180
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209158
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-july-15-1595071335.pdf
https://www.otsuka.co.jp/en/company/newsreleases/2020/20200616_1.html
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-april-3-2019-1554267295.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208992
https://www.pharmacompass.com/pdf/news/indoco-remedies-fails-edqm-inspection-1549481534.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203172
https://www.pharmacompass.com/pdf/news/Imprimis-Pharmaceuticals-Receives-FDA-Warning-Letter-1516167417.pdf
https://www.biospectrumasia.com/news/25/10065/fda-approves-bausch-lombs-lumify.html
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-november-22-2017-1511333424.pdf
http://www.prnewswire.com/news-releases/ocugen-announces-fda-acceptance-of-investigational-new-drug-application-for-ocu310-brimonidinesteroid-combination-therapy-and-initiates-proof-of-concept-study-for-treatment-of-dry-eye-disease-300524751.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209158
http://www.fiercepharma.com/marketing/allergan-takes-preventable-blindness-nationwide-vision-screening-push
http://www.prnewswire.com/news-releases/perrigo-announces-tentative-fda-approval-for-generic-version-of-suprep-oral-solution-and-confirms-patent-challenge-for-generic-version-of-mirvaso-gel-300316991.html
Market Place
Share 
